CORREVIO PHARMA CORP's ticker is CORV and the CUSIP is 22026V105. A total of 36 filers reported holding CORREVIO PHARMA CORP in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $17,000 | -52.8% | 45,429 | -50.0% | 0.00% | – |
| Q4 2019 | $36,000 | -60.0% | 90,858 | +100.0% | 0.00% | – |
| Q3 2019 | $90,000 | -8.2% | 45,429 | 0.0% | 0.00% | – |
| Q2 2019 | $98,000 | -7.5% | 45,429 | +34.4% | 0.00% | – |
| Q1 2019 | $106,000 | -36.9% | 33,798 | -50.0% | 0.00% | – |
| Q4 2018 | $168,000 | +24.4% | 67,596 | +100.0% | 0.00% | – |
| Q3 2018 | $135,000 | +7.1% | 33,798 | 0.0% | 0.00% | – |
| Q2 2018 | $126,000 | – | 33,798 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|